Search clinical trials for: Centanafadine SR

Total 508 results

Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit/Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Active, not recruiting

A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)

Attention Deficit/Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder

Attention-deficit Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Binge-Eating Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment

Smoking Cessation

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Adult Attention-deficit Hyperactivity Disorder (ADHD)

Australia
University of Alabama at Birmingham

Not yet recruiting

Effects of Sustained-release Oral Sodium Nitrite on Postoperative Pain and Recovery Following Total Knee Arthroplasty

Pain
G&E Herbal Biotechnology Co., LTD

Completed

Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis (AK)

Actinic Keratosis | Bowen's Disease

Taiwan
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

Adult ADHD

United States
NYU Langone Health

Terminated

Stress Reduction Intervention for Women With Ischemic Heart Disease

Ischemic Heart Disease

United States
AVAVA, Inc.

Completed

AVAVA SR-1 Wrinkles and BPL Study

Wrinkle | Benign Pigmented Lesion

United States
Stingray Therapeutics

Recruiting

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

Advanced / Metastatic Solid Tumor

Australia
Tan Tock Seng Hospital
Nanyang Technological University; Institute for Infocomm Research

Recruiting

Multimodal EEG and NIRS-based BCI With Assistive Soft Robotics for Stroke (MBCI-SR) (MBCI-SR)

Stroke

Singapore
Forest Laboratories

Completed

Safety Study of F2695 SR in Major Depressive Disorder (LVM-MD-04)

Major Depressive Disorder

United States
Pfizer

Completed

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Bacterial Infections
G&E Herbal Biotechnology Co., LTD

Completed

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

Actinic Keratosis

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Alzheimer Disease

Germany
Allysta Pharmaceutical
INC Research Australia Pty Ltd

Terminated

ALY688-SR in Generally Healthy Overweight or Obese Adults

Overweight and Obesity

Australia
Shanghai Jiao Tong University Affiliated Sixth...

Completed

The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma With CSPH

China
Hospital for Special Surgery, New York

Available

Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint

Arthroplasty of the PIP Joint

United States
University of Delaware

Completed

Neuromotor Control During Walking in Children With Cerebral Palsy

Cerebral Palsy

United States
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Terminated

Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients

Healthy
Hospital for Special Surgery, New York

Approved for marketing

Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device

Arthroplasty of the MCP Joint

United States
Mayo Clinic

Completed

Topical Agent for Treatment of Red Skin

Rosacea | Bilaterally Symmetric Red Skin on Cheeks

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

Depressive Disorder | Depression | Major Depressive Disorder
Orexigen Therapeutics, Inc

Completed

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

Obesity

United States
G&E Herbal Biotechnology Co., LTD

Completed

Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)

Genital Warts | Condylomata Acuminata | Condyloma Acuminata | Venereal Warts

Taiwan
The First Affiliated Hospital with Nanjing Medical...
National University Hospital, Singapore; University of Pennsylvania; General... and other collaborators

Unknown

CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF (STABLE-SR_II)

Atrial Fibrillation

China
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause

Hot Flashes | Menopause | Sleep Disorders
Columbia University
National Heart, Lung, and Blood Institute (NHLBI); NYU Langone Health

Completed

Impact of Sleep Restriction on Performance in Adults

Obesity | Sleep | Sleep Restriction

United States
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Using Novel Behavioral Approaches to Improve Long-Term Weight Loss Outcomes

Obesity

United States
G&E Herbal Biotechnology Co., LTD

Completed

Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

Actinic Keratosis

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Terminated

Study Evaluating Multiple Ascending Dose in Schizophrenia Patients

Healthy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Vasomotor Symptoms

United States
Shanghai 10th People's Hospital

Completed

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

Obesity
Neurocentria, Inc.

Completed

Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)

ADHD

United States
Cannabics Pharmaceuticals Inc.

Completed

Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients

Cancer Cachexia | Atypical Anorexia Nervosa

Israel

Search clinical trials for: Centanafadine SR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations